Antioxidant and Cholinesterase Inhibitory Activity of a New Peptide From Ziziphus jujuba Fruits

Author:

Zare-Zardini Hadi12,Tolueinia Behnaz3,Hashemi Azam2,ebrahimi Leila4,Fesahat Farzaneh56

Affiliation:

1. Young Researchers and Elite Club, Yazd Branch, Islamic Azad University, Yazd, Islamic Republic of Iran

2. Department of Pediatric Hematology, Oncology and Genetics Research Center, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Islamic Republic of Iran

3. Department of biology, University of Applied Science and Technology of Sistan and Baluchestan, Minushargh Branch, Zahedan, Islamic Republic of Iran

4. Department of Hematology, Iranian Blood Transfusion Organization, Tehran, Islamic Republic of Iran

5. Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Islamic Republic of Iran

6. Faculty of Pharmacy, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Islamic Republic of Iran

Abstract

Antioxidant agents and cholinesterase inhibitors are the foremost drugs for the treatment of Alzheimer’s disease (AD). In this study, a new peptide from Ziziphus jujuba fruits was investigated for its inhibitory activity against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzymes as well as antioxidant activity. This peptide was introduced as a new peptide and named Snakin-Z. The Snakin-Z displayed considerable cholinesterase inhibition against AChE and BChE. The half maximal inhibitory concentration (IC50) values of Snakin-Z against AChE and BChE are 0.58 ± 0.08 and 0.72 ± 0.085 mg/mL, respectively. This peptide has 80% enzyme inhibitory activity on AChE and BChE at 1.5 mg/mL. The Snakin-Z also had the high antioxidant activity (IC50 = 0.75 ± 0.09 mg/mL). Thus, it is suggested that Snakin-Z may be beneficial in the treatment of AD. However, more detailed researches are still required as in vivo testing its anticholinesterase and antioxidant activities.

Publisher

SAGE Publications

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3